Literature DB >> 22455385

Topical 1% oxytetracycline hydrochloride versus placebo in oral mucosa biopsy.

Pia López-Jornet1, Fabio Camacho-Alonso, Ascensión Martinez-Canovas, Miriam Sidrach-Cardona.   

Abstract

BACKGROUND: Oral surgical procedures produce side effects such as pain and inflammation, the magnitude of which depends on the degree of tissue damage produced.
OBJECTIVE: To explore the effectiveness and safety of the topical application of 1% oxytetracycline hydrochloride after biopsy of the oral mucosa.
METHODS: A randomized, double-blind, placebo- and no treatment-controlled study was conducted in 90 patients with lesions needing histopathologic analysis. The patients were divided into three groups. Group I (control) received no treatment; in group II, the site of surgical intervention was treated topically with 1% oxytetracycline hydrochloride three times a day for 1 week; and in group III, the patients were treated in the same way but with placebo. Using a visual analog scale, we determined the time of maximum postoperative pain.
RESULTS: Maximum pain intensity was recorded in the placebo group, with peak pain occurring 24 hours after surgery. The pain subsequently tended to decrease gradually over the 1-week period of the study. The maximum level of pain was significantly lower in group II than in the controls. No adverse effects were recorded.
CONCLUSIONS: Topical 1% oxytetracycline hydrochloride decreases pain symptoms after oral mucosa biopsy.
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22455385     DOI: 10.1111/j.1524-4725.2012.02399.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  1 in total

1.  Inhibitory effect of topical antibiotics/antiseptics administration on bacterial growth in the open wound of the jawbone surgery: Randomized controlled, preliminary study.

Authors:  Souichi Yanamoto; Sakiko Soutome; Shoma Tsuda; Kota Morishita; Saki Hayashida; Saori Harata; Maho Murata; Keisuke Omori; Satoshi Rokutanda; Masahiro Umeda
Journal:  J Dent Sci       Date:  2020-07-03       Impact factor: 2.080

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.